CD19 and glioblastoma: The presence of pericytes significantly increased CD19 CAR‐iNK cell migration toward GBM and reduced tumor cell proliferation, thus highlighting the therapeutic potential of CD19 CAR‐iNK cells for targeting pericytes within the GBM TME.